JP2012512389A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012512389A5 JP2012512389A5 JP2011540202A JP2011540202A JP2012512389A5 JP 2012512389 A5 JP2012512389 A5 JP 2012512389A5 JP 2011540202 A JP2011540202 A JP 2011540202A JP 2011540202 A JP2011540202 A JP 2011540202A JP 2012512389 A5 JP2012512389 A5 JP 2012512389A5
- Authority
- JP
- Japan
- Prior art keywords
- sample
- subject
- nucleic acid
- detection
- binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0822836.3 | 2008-12-15 | ||
| GBGB0822836.3A GB0822836D0 (en) | 2008-12-15 | 2008-12-15 | Method |
| PCT/GB2009/002885 WO2010070276A1 (en) | 2008-12-15 | 2009-12-15 | Method |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012512389A JP2012512389A (ja) | 2012-05-31 |
| JP2012512389A5 true JP2012512389A5 (enExample) | 2012-11-22 |
| JP5671475B2 JP5671475B2 (ja) | 2015-02-18 |
Family
ID=40326133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011540202A Expired - Fee Related JP5671475B2 (ja) | 2008-12-15 | 2009-12-15 | 方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20120027749A1 (enExample) |
| EP (1) | EP2370818A1 (enExample) |
| JP (1) | JP5671475B2 (enExample) |
| CN (1) | CN102301236B (enExample) |
| GB (1) | GB0822836D0 (enExample) |
| WO (1) | WO2010070276A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0919882A8 (pt) | 2008-10-30 | 2017-09-19 | Caris Life Sciences Luxembourg Holdings | Métodos para avaliar padrões de rna |
| WO2013022995A2 (en) * | 2011-08-08 | 2013-02-14 | Caris Life Sciences Luxembourg Holdings, S.A.R.L. | Biomarker compositions and methods |
| CN107254538A (zh) | 2008-11-12 | 2017-10-17 | 卡里斯生命科学瑞士控股有限责任公司 | 使用外来体来确定表现型的方法和系统 |
| US20130052647A1 (en) * | 2010-02-10 | 2013-02-28 | Marianna Goldrick | Methods for fractionating and processing microparticles from biological samples and using them for biomarker discovery |
| KR20130056855A (ko) | 2010-03-01 | 2013-05-30 | 카리스 라이프 사이언스 룩셈부르크 홀딩스 | 치료진단용 생물학적 지표들 |
| KR20130043104A (ko) | 2010-04-06 | 2013-04-29 | 카리스 라이프 사이언스 룩셈부르크 홀딩스 | 질병용 순환 생물학적 지표들 |
| US20140329334A1 (en) * | 2011-09-22 | 2014-11-06 | Universidad de losAndes | Method for monitoring, diagnosis and/or prognosis of acute kidney injury in early stage |
| JP6254951B2 (ja) * | 2012-01-24 | 2017-12-27 | ファイザー・インク | 哺乳類の対象における5t4陽性循環腫瘍細胞を検出するための方法および5t4陽性がんの診断の方法 |
| JP5969777B2 (ja) * | 2012-03-07 | 2016-08-17 | 国立研究開発法人医薬基盤・健康・栄養研究所 | 肺腺扁平上皮癌の腫瘍マーカー及び診断キット |
| SG10201404895XA (en) * | 2014-08-13 | 2016-03-30 | Agency Science Tech & Res | Diagnosis |
| CN105388055B (zh) * | 2015-12-11 | 2018-03-27 | 浙江省肿瘤医院 | 从尿液中分离肿瘤细胞来源的外泌体的方法 |
| CN105505877B (zh) * | 2015-12-11 | 2018-09-28 | 浙江省肿瘤医院 | 恶性胸腔积液中分离肿瘤细胞来源的外泌体的方法 |
| US10874610B2 (en) | 2016-10-19 | 2020-12-29 | Northwestern University | Extracellular vesicle-based diagnostics and engineered exosomes for targeted therapeutics against cancer |
| US12007394B2 (en) * | 2017-09-18 | 2024-06-11 | National Taiwan University | Biomarker for prognosis of thyroid cancer |
| WO2021231720A1 (en) * | 2020-05-15 | 2021-11-18 | Alexion Pharmaceuticals, Inc. | Method of using extracellular vesicles to detect complement activation, and uses thereof to assess and/or monitor treatment of a complement-mediated disease |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989007947A1 (en) * | 1988-03-04 | 1989-09-08 | Cancer Research Campaign Technology Limited | Improvements relating to antigens |
| WO2002018645A2 (en) * | 2000-08-28 | 2002-03-07 | Oncomedx, Inc. | 5t4 rna in plasma and serum as a marker for neoplastic disease |
| SE0102327D0 (sv) * | 2001-06-28 | 2001-06-28 | Active Biotech Ab | A novel engineered superantigen for human therapy |
| CA2555866A1 (en) * | 2004-02-16 | 2005-08-25 | Proteosys Ag | Diagnostic markers for cancer |
| DE102004038076A1 (de) * | 2004-02-16 | 2005-09-01 | Proteosys Ag | Diagnostische Marker für Krebs |
| CA2571070A1 (en) * | 2004-06-17 | 2006-01-05 | Mannkind Corporation | Tumor-associated antigen profiles in cancer diagnostics and immunotherapy |
| CN101035564A (zh) * | 2004-09-10 | 2007-09-12 | 惠氏公司 | 人源化的抗5t4抗体和抗5t4抗体/加利车霉素缀合物 |
| EP1724586A3 (en) * | 2005-05-21 | 2007-07-04 | ProteoSys AG | Annexin for cancer risk assessment |
| EP1724585A1 (en) * | 2005-05-21 | 2006-11-22 | ProteoSys AG | Annexin for cancer risk assessment |
| CN105734128B (zh) * | 2008-02-01 | 2021-05-18 | 总医院有限公司 | 微泡在医学疾病和病况的诊断、预后以及治疗中的用途 |
| CN107254538A (zh) * | 2008-11-12 | 2017-10-17 | 卡里斯生命科学瑞士控股有限责任公司 | 使用外来体来确定表现型的方法和系统 |
| GB201018480D0 (en) * | 2010-11-02 | 2010-12-15 | Oxford Biomedica Ltd | Factors |
-
2008
- 2008-12-15 GB GBGB0822836.3A patent/GB0822836D0/en active Pending
-
2009
- 2009-12-15 CN CN200980155784.2A patent/CN102301236B/zh not_active Expired - Fee Related
- 2009-12-15 WO PCT/GB2009/002885 patent/WO2010070276A1/en not_active Ceased
- 2009-12-15 JP JP2011540202A patent/JP5671475B2/ja not_active Expired - Fee Related
- 2009-12-15 US US13/139,682 patent/US20120027749A1/en not_active Abandoned
- 2009-12-15 EP EP09795519A patent/EP2370818A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012512389A5 (enExample) | ||
| CN109576368B (zh) | 用于诊断胰腺癌的组合物以及使用其诊断胰腺癌的方法 | |
| JP2008249727A5 (enExample) | ||
| JP2014527398A5 (enExample) | ||
| JP2013536442A5 (enExample) | ||
| AU2009205390A1 (en) | Compositions and methods of detecting post-stop peptides | |
| JP2014503180A5 (enExample) | ||
| JP2010530238A5 (enExample) | ||
| JP2009539082A5 (enExample) | ||
| WO2018210201A1 (zh) | 一种用于早期诊断、预测脓毒血症并发急性肾损伤的分子标记物、试剂盒及应用 | |
| US20190383809A1 (en) | A Novel Autophagy-Related Nourin Gene-Based RNA Network as Early Biomarkers for Cardiac Patients | |
| Li et al. | Proteome screening of pleural effusions identifies IL1A as a diagnostic biomarker for non-small cell lung cancer | |
| JP2023113877A (ja) | 膵がんの検出を補助する方法 | |
| JP2010502192A5 (enExample) | ||
| JP2012513584A5 (enExample) | ||
| EP4073510A1 (en) | Materials and methods for inflammatory molecular markers | |
| CN108913772B (zh) | 基于捕获测序的bMSI检测技术 | |
| JPWO2019117257A1 (ja) | 乳がんの検出を補助する方法 | |
| CN114277031A (zh) | hsa_circ_0006420环状RNA及其在胶质瘤诊断、预后评估中的应用 | |
| Iwano et al. | Characteristics of gastric B-cell lymphoma of mucosa-associated lymphoid tissue type involving multiple organs | |
| EP4520821A1 (en) | Microrna-derived rnas and polypeptides and uses thereof | |
| CN103487580A (zh) | Dkk1作为诊断标志物的用途 | |
| CN105203763B (zh) | 一种口腔癌特异性检测的试剂盒 | |
| JP2011528799A5 (enExample) | ||
| CN108384848A (zh) | 血清中circ_0021132作为深静脉血栓形成诊断标志物的应用 |